These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3285553)

  • 1. Serum beta 2-microglobulin in malignant lymphoproliferative disorders.
    Melillo L; Musto P; Tomasi P; Cascavilla N; Bodenizza C; Ladogana S; Carotenuto M
    Tumori; 1988 Apr; 74(2):129-35. PubMed ID: 3285553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
    Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
    Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
    Child JA; Kushwaha MR
    Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
    Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
    Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta 2-microglobulin in lymphoproliferative disorders].
    Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
    G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
    Pavlidis NA; Manoussakis MN; Germanidis GS; Moutsopoulos HM
    Med Pediatr Oncol; 1992; 20(1):26-31. PubMed ID: 1727208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
    Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
    Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 May; 37(5):479-87. PubMed ID: 1842146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.
    Milanovic N; Matkovic S; Ristic D; Jelic S; Petrovic M
    J BUON; 2012; 17(3):497-501. PubMed ID: 23033288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.
    Maio M; Pinto A; Carbone A; Zagonel V; Gloghini A; Marotta G; Cirillo D; Colombatti A; Ferrara F; Del Vecchio L
    Blood; 1990 Aug; 76(4):783-90. PubMed ID: 1974471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
    Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
    Ir J Med Sci; 2024 Jun; 193(3):1201-1207. PubMed ID: 38270775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum selenium levels in malignant lymphoproliferative diseases.
    Calautti P; Moschini G; Stievano BM; Tomio L; Calzavara F; Perona G
    Scand J Haematol; 1980 Jan; 24(1):63-6. PubMed ID: 7367833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoid cell glycosidases in various forms of lymphoproliferative disorders].
    Ushakova NA; Vlasova AL; Preobrazhenskaia ME; Samoĭlova RS; Polianskaia AM; Grigor'eva MA; Baĭdurin SA
    Vopr Med Khim; 1991; 37(6):78-82. PubMed ID: 1812621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
    Kłoczko J; Zuch A; Bielawiec M; Buluk K
    Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
    Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
    Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.